Anu Airaksinen
Turku PET Centre anu.airaksinen@utu.fi +358 29 450 2199 +358 50 470 7622 : https://orcid.org/0000-0002-5943-3105 |
radiopharmaceutical chemistry; PET radiochemistry; image guided drug delivery; pretargeted PET imaging; theranostics; nanotheranostics
2 of 10
- In Vivo Imaging of [60]Fullerene-Based Molecular Spherical Nucleic Acids by Positron Emission Tomography2023
- Molecular Pharmaceutics
- Pretargeted PET imaging of trans-cyclooctene functionalized spherical nucleic acids (2023)
- Nuclear Medicine and BiologyRSC Advances
- Radiolabelling of peptides with tetrazine ligation based on the inverse electron-demand Diels-Alder reaction: rapid, catalyst-free and mild conversion of 1,4-dihydropyridazines to pyridazines (2023)
- Targeting mammary-derived growth inhibitor for positron emission tomography imaging of breast cancer brain metastasis2023
- Nuclear Medicine and BiologyACS Omega
Airaksinen Anu, Laakkonen Pirjo, Li Xiang-Guo - Tetrazine Glycoconjugate for Pretargeted Positron Emission Tomography Imaging of trans-Cyclooctene-Functionalized Molecular Spherical Nucleic Acids (2023)
- Development of [18F]AmBF3 Tetrazine for Radiolabeling of Peptides: Preclinical Evaluation and PET Imaging of [18F]AmBF3-PEG7-Tyr3-Octreotide in an AR42J Pancreatic Carcinoma Model (2022)
- Bioconjugate Chemistry
- Development of 68Ga-Labeled Hepatitis E Virus Nanoparticles for Targeted Drug Delivery and Diagnostics with PET (2022)
- Molecular Pharmaceutics
- (2022)
- Nuclear Medicine and BiologyBioconjugate Chemistry
- Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [Zr-89]Zr-DFO-PEG(5)-Tz (2022)
- Radiosynthesis and biological evaluation of [18F]CooP: a brain-homing peptide for imaging glioblastomas using positron emission tomography (2022)
- Nuclear Medicine and Biology
UTU Research Portal